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Ca2+-Calmodulln Dependent Inactivation of TRPM2
by
Oies Hussein
The interaction of Ca2+-calmodulin is known to promote Ca2+-dependent negative
ry I f\  i
feedback on the activity of various Ca permeable channels through Ca -dependent 
inactivation. Our laboratory has previously observed a progressive, time-dependent 
inactivation of TRPM2 (melastatin-related transient receptor potential channel 2). Currents 
were evoked from HEK 293T cells stably expressing TRPM2, through-the intracellular 
application of ADPR. TRPM2-mediated currents developed rapidly, reaching a peak and
A  I
decaying to a steady state in the continued presence of extracellular Ca . Full recovery of 
TRPM2 channels from inactivation was dependent on ADPR concentration. Inactivation 
was reduced at more depolarized membrane potentials, consistent with a reduced driving 
force and influx of Ca2+. The extent o f inactivation was dependent on extra- and 
intracellular Ca2+. Exogenous application of calmodulin results in a slower recovery of 
TRPM2 channels, in addition to increased inactivation. In conclusion, I have shown that 
TRPM2 channels are susceptible to Ca2+-dependent inactivation involving calmodulin.
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ADPR: Adenosine diphosphate ribose
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AMP: Adenosine monophosphate
BAPTA: 2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid 
BD: Bipolar disorder
cADPR: cyclic adenosine diphosphate ribose
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CCD: Coiled-coiled domain
EC50: Half maximal effective concentration
ECS: Extracellular solution




GFP: Green fluorescent protein
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HEK 293: Human embryonic kidney cell line
ICS: Intracellular solution
Iss/Ip: Steady state/peak ratio (estimate of the extent of inactivation)
La3+: Lanthanum
MEM: Modified Eagle Medium
mPTP: mitochondrial transition pore opening
NAD+: Nicatinamide adenine dinucleatide
NMDA receptor: N-Methyl-D-aspartic acid receptor
NUDIX: Nucleoside diphosphate coupled to a varying moiety X (NUDT9-H)
O Ca2+: Ca2+-free extracellular solution




ROS/RNS: Reactive oxygen/nitrogen species
t: time constant of recovery measured by tau value of exponential decay fit 
TRP: Transient receptor potential
TRPM2: Melastatin-related transient receptor potential channel 2
VGCC: Voltage-gated calcium channels





The role of Ca2+ ions in cell signalling has been demonstrated in many cellular 
processes including transmitter release, cell proliferation and cell death (Jiang et al., 2010; 
Nilius et al., 2007). The gradient maintained in cells between the free intracellular [Ca2+] 
([Ca2+]i) (approximately 100 nM) and extracellular [Ca2+] (in the mM ranges) is important 
in cell signalling (Clapham, 2007). Ca2+ channels represent a diverse family of channels 
with broad physiological and pathophysiological functions. Voltage-gated calcium 
channels (VGCC) are an example of Ca channels that regulate fast Ca signalling and 
which cause dramatic changes in intracellular [Ca2+] (Clapham, 2007). An important 
physiological role of Ca2+ channels is to maintain proper [Ca2+] homeostasis (Gordon- 
Shaag et al., 2008). Drastic changes to the [Ca2+]i could result in Ca2+ dysregulation. 
Furthermore, Ca2+ dysregulation due to the inability to buffer excessive levels of [Ca2+]i 
may result in subsequent cell death. Thus maintaining Ca2+ homeostasis is one o f many
A  i
essential mechanisms amongst Ca channels.
A diverse superfamily of Ca2+ channels referred to as transient receptor potential 
(TRP) channels were identified due to their homology to TRP proteins, discovered in 1977 
in Drosophila phototransduction mutants (Minke, 1977). Many TRP channels demonstrate 
some permeability to Ca2+ but to varying degrees (Clapham et al., 2001; Clapham, 2002; 
Montell, 2001; Zhu and Bimbaumer, 1998). TRPM (melastatin-related transient receptor 
potential) subfamily have been an emerging group of channels that exhibit wide range of
ir
physiological and pathological functions (Nilius et al., 2005). A growing body of research 
has focused on TRPM2 (melastatin-related transient receptor potential channel 2) due to its 
potential role in cell death (Nilius et al., 2005). TRPM2 channels are non-selective cation
2
channels that exhibit a strong requirement of intracellular Ca for activation. Indicating 
that the influx of Ca2+ represents an important determinant of their physiological role 
(Gordon-Shaag et al., 2008). Consequently the dysrégulation of [Ca2+]i by TRPM2 
channels may lead to cell death and disease. There are various diseases associated with 
uncontrolled levels of [Ca2+]i including; Alzheimer’s disease (AD), Parkinson’s disease 
(PD), Western Pacific amyotrophic lateral sclerosis (WP-ALS), ischemic stroke and bipolar 
disorder (Xu et al., 2006; Xu et al., 2009). Therefore the role of TRPM2 with respect to 
[Ca2+]i regulation and cell death makes it an attractive therapeutic target for diseases.
1.2TRPM2:
There are 28 mammalian homologues of TRP, which fall into six groups: TRPC 
(canonical), TRPV (vanilloid), TRPM (melastatin), TRPA (ankyrin), TRPP (polycystin) 
and TRPML (mucolipin)(Jiang et al., 2010). TRPM2, (melastatin-related transient receptor 
potential channel 2) is a member of the TRP family of non-selective cation channels. In 
addition to permeability to Na+ and K+, TRPM2 has demonstrated substantial permeability 
to Ca2+ (Hara et al., 2002; McHugh et al., 2003; Perraud et al., 2001; Sano et al., 2001). 
This channel is activated in response to oxidative stress (reactive oxygen species) thus 
acting as a redox sensor (Naziroglu and Luckhoff, 2008a; Naziroglu and Luckhoff, 2008b). 
Although TRPM2 is expressed predominately in the brain, it has been detected in many 
other tissues such as: bone marrow, spleen, heart, leukocytes, lung and liver (Du et al., 




1.3 Topology of TRPM2
TRPM2, (previously named TRPC7 and LTRPC-2) is a tetrameric assembly of four 
subunits which form a pore that is permeable to K+, Na+ and Ca2+ ions. Each of the four 
subunits contains 6 membrane-spanning domains, with long cytoplasmic N- and C- 
terminal tails. There is also a pore-forming re-entrant loop located between transmembrane 
domains 5 and 6 (Fig. 1). There is a region in the N-terminus of approximately 700 amino 
acids which is highly conserved among all TRPM family members (Perraud et al., 2003). 
This region is referred to as the TRPM homology domain, and evidence hints that this 
region regulates assembly and/or surface expression of TRPM2. The C-terminus contains 
a TRP domain which consists of highly conserved residues amongst TRP family members 
and a coiled-coiled domain (CCD) consistent in all TRPM channelsTThe TRP domain 
consists of a 23- to 25-amino acid region that includes two distinct TRP boxes; TRP box 1 
and TRP box 2 (Montell, 2005). TRPM subfamily contains a less conserved TRP box 1 
region of 5-amino acid (Trp-Lys-Phe-Gln-Arg), in comparison to TRPC which has a fully 
conserved region amongst the subfamily (Clapham, 2003; Montell, 2005). TRP box 2 
within the TRP domain of TRPM2 is a proline-rich motif (Montell, 2005). Other than being 
conserved amongst TRPM subfamily, the role of the TRP domain is not fully understood. 
Studies have predicted the presence of two CCD, one in the C-terminus and the other in the 
N-terminus (Mei and Jiang, 2009). The CCD in the C-terminus has been shown to be 
involved with TRPM2 subunit-subunit interactions and formation of the tetrameric channel 
(Jiang et al., 2010; Mei et al., 2006; Mei and Jiang, 2009). Mei et al. (2009) determined that 
the CCD in the N-terminus was not involved with subunit interactions or formation of 




terminus of TRPM2 was important in TRPM2 protein expression (Mei and Jiang, 2009). 
Another domain located in the C-terminus, the NUDT9-H domain is a unique sequence 
found in TRPM2. This region contributes to the gating of TRPM2 by ADPR (adenosine 
diphosphate ribose) (McHugh et al., 2003; Perraud et al., 2001).
;
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Figure 1: Transmembrane topology of TRPM2. TRPM2 is composed of 6 membrane- 
spanning domains with a pore-forming re-entrant loop locates between transmembrane 
domains 5 and 6. The long cytoplasmic C terminal tail is the site of the NUDIX (nucleoside 
diphosphate coupled to a varying moiety X) motif which is responsible for binding of 
ADPR. Localized in the N terminal tail of the channel is the CaM binding motif which is 
the site of Ca2+-CaM interaction.
6
1.4 Pharmacological properties of TRPM2
Ligand for TRPM2:
The binding of ADPR to an enzyme motif (NUDT9-H), localized within the 
intracellular C-terminal tail of the channel, contributes to the gating of TRPM2; effectively
, V
ADPR is an intracellular ligand (Perraud et al., 2001; Perraud et al., 2003). The 270 amino 
acid C-terminal NUDT9-H domain is homologous to the mitochondrial NUDT9 enzyme 
(Perraud et al., 2003). This NUDIX domain is found in enzymes which hydrolyze 
nucleoside diphosphates (Bessman et al., 1996). The NUDT9-H domain in TRPM2 
hydrolyze ADPR to AMP and ribose-5-phosphate, thus being an ADP-ribose 
pyrophosphatase (Perraud et al., 2001). To determine the role o f ADPR in gating and 
regulation o f TRPM2, ADPR was administered within the intracellulaFsolution in whole 
cell recordings. Human embryonic kidney cell line (HEK 293) with a Flag-tagged TRPM2 
construct was utilized to determine the role o f ADPR (Perraud et al., 2001). Concentration- 
response curve analysis, performed by Perraud et al., (2001), support an ADPR-dependent 
gating o f TRPM2 through the interaction of ADPR with NUDT9-H domain (Perraud et al., 
2001). In addition to the lack of enzymatic activity o f the NUDT9-H domain, the direct 
interaction of ADPR with NUDT9-H supports channel opening due to conformational 
changes (Perraud et al., 2001; Perraud et al., 2003). In the presence of 100 pM ADPR, 
recordings from HEK cells stably expressing TRPM2, demonstrated large inward and 
outward currents which reversed at 0 mV (indicating that there is no net movement of ions 
at 0 mV) (Perraud et al., 2001). The reversal at 0 mV suggests that TRPM2 is a non- 
selective cation channel. Furthermore, the voltage-relation for TRPM2 is linear suggesting 
channel gating is independent o f voltage.
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Other Activators:
The binding of intracellular NAD+ (nicatinamide adenine dinucleotide) might also 
directly gate TRPM2. Unlike ADPR which can regulate TRPM2 at micromolar ranges 
(EC50 o f 10-90pM) NAD+ requires millimolar concentrations (EC50 of 1-1.8 mM) (Hara et 
al., 2002; Naziroglu and Luckhoff, 2008a; Sano et al., 2001; Sumoza-Toledo and Penner, 
2010). To determine whether NAD+ directly binds and activates TRPM2, binding assays 
were performed (Grubisha et al., 2006). In contrast to assays for ADPR, NAD+ displayed 
negligible binding to the cytoplasmic domain (NUDT9-H domain) of TRPM2 (Grubisha et 
al., 2006). Other groups indicated that direct TRPM2 activation by NAD+ is unlikely. They 
suggested that the NAD+-activated currents are likely due to ADPR contamination (Beck et 
al., 2006; Grubisha et al., 2006; Kolisek et al., 2005). Another problem with evidence that 
NAD+ plays a direct role with gating TRPM2 arises since ADPR is a direct degradation 
product of NAD+ (Scharenberg, 2005). Several other NAD metabolites can activate 
TRPM2 including; 2-O-acetyl-ADPR, cyclic ADPR (cADPR) and nicotinic acid-adenine 
dinucleotide phosphate (Fliegert et al., 2007; Grubisha et al., 2006). There seems to be 
synergistic effects of the accumulation of ADPR with any of the other activators (Beck et 
al., 2006). TRPM2 is a temperature sensitive channel that can be activated by an increase in 
temperature (Togashi et al., 2006). Whole-cell recordings were performed with the addition 
o f either NAD or ADPR. Currents from HEK-293 cells exposed to warm temperatures 
(>35C) resulted in a robust activation of the currents. To further demonstrate the effects of 
temperature on TRPM2, Togashi et al., (2006) administered cADPR to the intracellular 
solution (ICS) (Togashi et al., 2006). Although cADPR does not activate TRPM2 at room
8
temperature, the co-administration of cADPR and heat (35C) resulted in robust activation 
of TRPM2 currents (Togashietal., 2006).
Another known activator of TRPM2 is oxidative stress. Oxidative stress results in 
an increase in reactive oxygen species/reactive nitrogen species (ROS/RNS), including 
hydrogen peroxide (H2O2) (Naziroglu and Luckhoff, 2008b) which activates TRPM2. 
However, the mechanism in which H2O2 activates the channel is debated.
Recent literature from various groups suggests H2O2 activates the channel through 
an ADPR-dependent process. Production of H2O2 in the cytosol from oxidative stress 
causes an accumulation of ADPR (Hara et al., 2002; Kuhn et al., 2005; Perraud et al., 
2005). The production of free ADPR occurs in the mitochondria and nucleus (Perraud et 
al., 2005). Experiments with mutations of the NUDT9-H domain significantly reduced 
activation by H2O2 and ADPR (Perraud et al., 2005). This suggested the importance of the 
binding o f ADPR to the activation of TRPM2 by H2O2. The production of ADPR following 
DNA damage by ROS/RNS, is attributed to a pathway involving PARP (goly4DPR- 
£olymerase) (Kuhn et al., 2005). PARP inhibitors were utilized to inhibit ADPR production 
following oxidative stress and prevent or reduce the current of TRPM2 (Fonfria et al., 
2004; Wilkinson et al., 2008). It was observed that the PARP inhibitors abolished the H2O2 
evoked rises in [Ca2+]i and inhibited cell death (Fonfria et al., 2004). Over expression of 
PARP-1 (mediates ADPR production induced by DNA damage) significantly restored 
currents in DT40 lymphocyte cells deficient in PARP expression (Buelow et al., 2008; 
Kuhn et al., 2005). In summary the ADPR-dependent process involves the production of 
ADPR from the nucleus and mitochondria, and results in TRPM2 activation by free ADPR 
in the cytosol.
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An alternative mechanism involves an ADPR-independent process. TRPM2 
transfected HEK cells were utilized in a set of experiments whereby H2O2 was 
administered (Wehage et al., 2002). Wehage et al., (2002) administered H2O2, which 
caused an increase in [Ca2+]i consistent with previous experiments from another group 
(Perraud et al., 2005). A splice variant with two deletions in the C-terminus (TRPM2-AC), 
were prepared in HL-60 cells and neutrophil granulocytes. Results demonstrated that 
administered H2O2 activated TRPM2-AC, similarly to wild-type TRPM2. However, 
recordings with TRPM2-AC did not respond to ADPR, suggesting that oxidative stress via 
H2O2 was sufficient to activate TRPM2 (Perraud et al., 2005). In summary, the role of
TRPM2 channels as sensors of oxidative stress results in a Ca2+ influx evoked by H2O2
• 1 ' : /
(ADPR-dependent and independent mechanisms) which may mediates cell death 
(Naziroglu and Luckhoff, 2008b).
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Figure 2: Intracellular ADPR production. The first source of intracellular ADPR 
production is through the mitochondria ( 1 ), and the second source is from DNA repair 
enzymes, PARG (polyADPR-glycohydrolase) and PARP (polyADPR-polymerase) (2).
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Pharmacology of TRPM2:
There are no specific inhibitors of TRPM2. However adenosine monophosphate 
(AMP) has been demonstrated to reduce TRPM2 activation by binding to the NUDT9-H 
domain, thereby preventing ADPR binding (Grubisha et al., 2006). In addition, 8-Br- 
cADPR has been shown to decrease TRPM2 channel activation caused by ligands 
including, cADPR and NAD+ (Beck et al., 2006; Kolisek et al., 2005; Lange et al., 2008; 
Togashi et al., 2006).
The following pharmalogical agents have been reported to inhibit TRPM2 channels; 
flufenamic acid (FFA), imidazol anti-fungal agents (clotrimazole and econazole), N-(p- 
amylcinnamoyl) anthranilic acid (ACA), and 2-aminoethoxydiphenyl borate (2-APB) (Hill 
et al., 2004a; Hill et al., 2004b; Jiang et al., 2010; Togashi et al., 2006). However none of 
the inhibitors are TRPM2 selective and may inhibit a wide variety of ion channels.
Due to PARPs involvement with TRPM2 activation, PARP inhibitors were tested 
by various groups as a means of reducing TRPM2 activation. The PARP family contains 
approximately 18 proteins (Ame et al., 2004; Eisfeld and Luckhoff, 2007); however the 
focus of most research is on poly(ADPR) polymerase-1 (PARP-1), since PARP-1 is 
involved in the pathway that produces ADPR from the nucleus or mitochondria (Eisfeld 
and Luckhoff, 2007; Kuhn et al., 2005). Various PARP inhibitors have been demonstrated 
to reduce or block the increase in [Ca2+]i induced by H2O2 including: PJ34, DPQ, 
SB750139-B and ABT-888 (Donawho et al., 2007; Fonfria et al., 2004; Kuhn et al., 2005; 
Yang et al., 2006). A caveat that arises with these PARP inhibitors is that the 
concentrations required to block H202-induced TRPM2 activation is much greater than 
those required in-vitro (Eisfeld and Luckhoff, 2007; Scharenberg, 2005). In addition, the
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concentrations required for inhibition varies greatly amongst PARP inhibitors. To 
determine if  PARP inhibitors directly interacted with TRPM2, Fonria et al., (2004) 
performed experiments with PARP inhibitors in the presence or absence of ADPR in the 
ICS. Activation of TRPM2 currents was observed under both conditions suggesting that 
inhibitors do not interfere with TRPM2 directly but rather act by limiting ADPR 
production (Fonfria et al., 2004). There is evidence that PARP inhibitors are involved with 
blocking TRPM2 activity induced by oxidative stress; however more extensive research 
will be required to determine the mechanism and efficacy of these inhibitors.
Lanthanum (La3+) and gadolinium (Ga3+) ions are non-specific channel blockers 
known to inhibit TRP channels (Hardie, 2003; Minke, 2010). More specifically, two 
channels within the TRPM family are susceptible to inhibition by La and Ga , namely 
TRPM3 and TRPM7 (Harteneck, 2005). In contrast, TRPM2 was demonstrated to be 
insensitive to inhibition by La3+ and Ga3+ (Harteneck, 2005).
1.5 Ca2+ and TRPM2 function
Experiments performed by Perraud et al., (2001) suggested the possibility that Ca
may facilitate TRPM2 activation by ADPR. (Perraud et al., 2001). In these experiments
they varied the intracellular Ca concentration ([Ca ]¡) during their recordings and
demonstrated that elevating intracellular Ca potentiated the development and peak
amplitude o f ADPR-evoked TRPM2 currents, (Perraud et al., 2001).This further suggested
a synergistic effect of intracellular Ca and ADPR on TRPM2 activation. Interestingly,
subsequent studies demonstrated that TRPM2 channel function was also dependent on
extracellular Ca2+ (Hara et al., 2002).This dependence was serendipitously observed while
conducting ion substitution experiments. Indeed currents were abolished when extracellular
13
Ca2+ was omitted from the extracellular solution (ECS) (Csanady and Torocsik, 2009; Hara 
et al., 2002; McHugh et al., 2003; Starkus et al., 2007). Similarly, McHugh et al., (2003)
A  i ■
substituted equimolar concentrations of Ba for Ca which resulted in a rapid inhibition of 
TRPM2 channel currents (McHugh et al., 2003). This demonstrated that Ca2+-free ECS 
could be administered during whole-cell recordings to turn the channel off. This suggested 
that the presence of intracellular Ca was necessary for channel activation through Ca 
influx (Starkus et al., 2007). The mechanism underlying this Ca2+-dependence remained 
unknown until a consensus IQ-like motif for calmodulin (CaM) binding was identified 
within the N-terminus of TRPM2. This motif was shown to play an essential role with
A  I
respect to channel regulation via intracellular Ca -CaM (McHugh et al., 2003; Starkus et 
al., 2007). This was demonstrated by showing Ca2+ influx enhanced the interaction of CaM 
and Ca2+ with TRPM2 at the IQ-like motif (Tong et al., 2006).
1.6 Calmodulin
Calmodulin is a ubiquitously expressed Ca binding protein, containing four EF- 
hand motifs, each of which can bind Ca2+. Ca2+ binding to these EF hands promotes a 
conformational change within the complex allowing CaM to interact with other proteins
I
(Gordon-Shaag et al., 2008; Togashi et al., 2006). CaM is well known to serve as a Ca
. . .  «, 
sensor for various ion channels (voltage- and ligand-gated) that are regulated by Ca
(Saimi and Kung, 2002). For example, CaM has also been demonstrated to be involved
with Ca -dependent activation observed in many types of voltage-gated calcium channels
(VGCCs) (McHugh et al., 2003; Wykes et al., 2007; Xia et al., 1998). L-type calcium
channels are amongst one type of voltage-gated calcium channels that demonstrate Ca2+-
dependent activation which involves CaM (Imredy and Yue, 1994; Zuhlke et al., 1999;
14
Zuhlke et al., 2000; Zuhlke and Reuter, 1998). As noted in the preceding section, the 
regulation of TRPM2 channels by Ca2+ depends on the interaction between intracellular 
Ca2+ and CaM (Ca2+-CaM). Although it has been observed that extracellular Ca2+ causes
A  ,
activation, there is little evidence to suggest that it is due to the action of Ca at an external 
regulatory site. McHugh et al., (2003) buffered free [Ca2+]i to 100 nM using BAPTA (2- 
bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid) to determine if  the effect of Ca 
occurred at an intracellular or extracellular site (McHugh et al., 2003). The reduction in the
A  I ^  I
effect of extracellular Ca on currents using BAPTA, demonstrated that the effect of Ca 
was not at an extracellular site. Instead, Ca2+ binding from an intracellular domain within 
TRPM2 channels appeared to be critical for activation (McHugh et al., 2003).
Starkus et al., (2007) administered a known CaM antagonist, calmidazolium, to 
determine the role of CaM with respect to activation of TRPM2 channels (Starkus et al., 
2007). In the presence of calmidazolium activation of TRPM2 was significantly reduced 
suggesting that CaM contributed to TRPM2 activation (Starkus et al., 2007). Experiments
using CaM mutants incapable of binding Ca2+, provided further evidence for a role of CaM.
2+VThe CaM mutants were prepared by aspartic acid substitutions in all four Ca binding sites 
on the EF hand motifs of CaM (Tong et al., 2006). Coexpression of CaM and CaM mutants 
resulted in a decrease in the activation of TRPM2 currents measured by the rate of rise and 
the peak amplitude of the current (Tong et al., 2006). These results indicated that CaM is 
the Ca2+ sensor responsible for activation o f TRPM2, and also demonstrated that mutated 
CaM competed with endogenous CaM for binding. Since half of CaM is associated with 
the plasma membrane and the rest is free in the cytoplasm and nucleus, 
coimmunoprecipitation was performed by Tong, Q et al., (2006) to determine how CaM
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interacts with TRPM2. It was determined that CaM directly interacts with TRPM2 at both 
N and the C termini, however higher affinity CaM binding at a site residing within the N 
terminus was observed (Tong et al., 2006). The sequence on the N terminus is defined as a 
IQ-type consensus motif which is situated between amino acids 406-416 (Tong et al., 
2006). The importance of this sequence was determined using site-directed mtutagenesis 
experiments. It was demonstrated that mutations to only two amino acids within the IQ- 
motif resulted in significant reduction in CaM binding. However, binding of CaM was still 
observed in TRPM2(IQ-mutants) suggesting that CaM may bind to other regions of 
TRPM2.
1.7 Ca2+-dependent inactivation
In addition to regulating Ca2+-dependent activation, CaM plays a vital role with
Ca2+-dependent inactivation described in L-type calcium channels. Inactivation is
important to maintaining physiological levels of Ca , acting as a negative feedback
mechanism. It has been demonstrated that the binding of Ca to the long cytoplasmic, C-
terminal tail of the aic subunits in L-type calcium channels is responsible for the observed
Ca2+ dependent inactivation (Zuhlke et al., 2000; Zuhlke and Reuter, 1998). However the
location o f the Ca2+binding site on the C-terminal tail has been debated. Experiments with
deletions o f the first 8 amino acids of the IQ-motif in the C-terminal tail of the aic subunit
resulted in abolishment of Ca2+-dependent inactivation (Zuhlke and Reuter, 1998). This
provided evidence for Ca2+-dependent inactivation of L-type calcium channels, but little is
known about the interaction with CaM. A CaM mutant was prepared to test the
involvement of CaM with respect to Ca2+-dependent inactivation. The CaM mutant
consisted o f an aspartate substitution for alanine in three o f four of the Ca -binding EF-
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hand motifs (Xia et al., 1998). Expression of the CaM mutant inhibited Ca2+-dependent 
inactivation o f L-type calcium channels. This suggests that CaM plays a crucial role in the 
Ca2+-dependent inactivation of L-type calcium channels. The role of CaM with regards to 
Ca2+-dependent activation and inactivation make L-type channels unique. Another example 
of Ca2+-dependent inactivation is present in NMDA (ion-channel), whereby it is regulated 
by the binding of Ca2+-CaM with the NR1 subunit o f NMDA (Lu et al., 2000; Zhang et al., 
1998). The administration of CaM to the intracellular solution resulted in an increase in the 
Ca2+ dependent inactivation o f the currents (Lu et al., 2000; Xia et al., 1998). In summary 
the interaction of Ca2+-CaM has been demonstrated to be essential to Ca2+-dependent 
regulation (activation or inactivation, or both) in various Ca channels.
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Figure 3: Schematic of TRPM2 illustrating Ca2+-CaM dependent regulation.
Localized in the N terminal tail of the channel is an IQ-type CaM binding motif (amino 
acids 406-416) a site of Ca2+-CaM interaction.
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1.8 Hypothesis and objectives
Activation of TRPM2 channels has been well characterized (Tong et al., 2006); 
however, inactivation of TRPM2 channels remains poorly understood. In preliminary 
recordings we observed a time-dependent inactivation process evident in voltage-clamped 
recordings from HEK 293 cells stably expressing TRPM2. The tight regulation of 
intracellular Ca2+ is critical for maintaining physiologically ideal Ca2+ concentrations 
within the cell, important for proper function of cells. Ca2+- and CaM- dependent feedback 
regulation represents a recurring theme among Ca permeable channels (voltage- and 
ligand-gated) (Saimi and Kung, 2002). Therefore, we hypothesize that the interaction of 
Ca2+ and CaM with TRPM2 plays a role in the inactivation of TRPM2 channels.
With the following specific research objectives in mindT"'experiments were 
performed to characterize the Ca2+-dependent inactivation observed in TRPM2 as follows:
1) To determine the ADPR concentration-dependence of TRPM2 inactivation 
and recovery.
2) To determine the dependence of inactivation on voltage.
3) To determine the dependence o f inactivation on extracellular Ca .
4) To determine the dependence of inactivation on intracellular Ca .





HEK 293 cells stably expressing TRPM2 were provided by Dr. A. M. Sharenberg 
(University of Washington and Children’s Hospital and Medical Center, Seattle, 
Washington). These cells contained a flag-tagged TRPM2 construct which is inducible 
(Perraud et al., 2001). Cells were cultured at 37°C with 5% CO2 in Dulbecco’s Modified 
Eagle Medium (Sigma). Media contained 10% fetal bovine serum and 1% 
penicillin/streptomycin (Invitrogen). Doxycycline (lpg  m l'1) was administered to cells 12- 
24 hours before experiments.
HEK 293 cells stably expressing TRPM2 were held at -60 mV during whole-cell 
voltage-clamp recordings (unless otherwise indicated), performed utilizing Axopatch-IB 
amplifier (Molecular Devices, Sunnyvale, CA). Currents were evoked through the 
intracellular application of ADPR (0.1-1 mM). Extracellular solutions containing various 
Ca2+ concentrations were applied using a multi-barreled fast perfusion system (Figure 4). 
The intracellular solution (ICS) contained (in mM): 130 CsGluconate, 10 HEPES, 2
MgCk, 1 CaCk, 0.1-1 ADPR, 20 EGTA (ethylene glycol tetraacetic acid), pH 7.3 (adjusted
\
with CsOH) and osmolarity between 295 and 300 mOsm. The final resistance of ICS-filled 
electrodes was between 3 and 5 MG. The standard extracellular solution (ECS) was 
composed of (in mM): 140 NaCl, 5.4 KC1, 25 HEPES, 33 glucose, 1 MgCl2, pH of 7.4 
(adjusted with NaOH) and osmolarity between 310 and 315 mOsm. ECS containing Ca2+ 
was prepared with 2mM CaCl2. When omitting extracellular Ca2+ from the ECS (Ca2+-free 
ECS), equimolar substitution with BaCl2 (2mM) was employed in order to maintain a 
constant extracellular osmolarity and total divalent concentrations. All data collected was 
filtered at 2kHz, digitized and acquired utilizing pClamp (Molecular Devices).
2.1 Whole-cell recordings from HEK 293 cells
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Figure 4: Schematic of whole cell recording from HEK 293 cells stably expressing 
TRPM2. (A) Illustration of the multi-barreled fast perfusion system used during whole­
cell recordings to administer various solutions. (B) HEK 293 cells stably expressing 
TRPM2 viewed under phase constrast (Lidia Brandes).
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2.2 Single-point mutation protocol for calmodulin mutants
CaMl sequence was first cloned from a human cDNA library by PCR cloning. 
Note, this sequence has 100% homology at the amino acid level to the mouse sequence. 
The resulting PCR product, from CaMl primers, was run on a 1.2% agarose gel. The 
CaMl band was cut out and the DNA was extracted. The CaMl DNA was digested with 
AscI and Notl for 2 hours at 37°C and ligated to pCDNA3.1 and pIRESpuro-Flag plasmids. 
Transformed JM109 bacteria with the ligation mix and plated on LB-Amp agar plates 
overnight at 37C. The colonies were picked and plasmid DNA extracted. Plasmids were 
analyzed by restriction digest with AscI and Noth The positive plasmid was sequenced and 
confirmed. ^
Three functional dominant negative CaMl mutants were prepared by single point 
mutations at the EF hands on either the N-terminus or C-terminus of CaMl. The four EF 
hands correspond to amino acids 21, 57, 94 and 130. CaMi^ mutant was prepared by 
substituting aspartate (D) for alanine (A) at amino acid 21 and 57 (EF hands 1 and 2 in 
Figure 5A). CaM3>4 mutant was prepared by substituting aspartate (D) for alanine (A) at 
amino acid 94 and 130 (EF hands 3 and 4 in Figure 5A). Lastly, CaMij2,3,4 mutant was 
prepared by substituting aspartate (D) for alanine (A) at all four EF hands.
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Figure 5: Calmodulin mutant. (A) Schematic of Calmodulin. Three Calmodulin mutants 
were prepared with single point mutations at the EF hands illustrated by the red filled 
circles. (B) HEK 293 cells stably expressing TRPM2 with transfected functional dominant 
negative CaM mutants, in comparison to (C) the same cells under fluorescence indicating 
cells expressing GFP and the desired DNA.
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Cells were plated onto 35 mm dishes and maintained until reaching 90% confluence 
before transfection with Lipofectamine 2000. Cells were incubated with 1ml Opti-MEM 
per 35 mm plate for at least 1 hour prior to transfection. For each transfection sample, 
complexes were prepared as follows:
a. Tube 1 contained: 10 pg DNA (7.5 pg pCDNA 3.1 CaM mutants and 2.5 pg 
GFP-pCDNA 3) and 1250 pi Opti-MEM. GFP tagging was implemented to 
fluorescently visualize the presence of the CaM mutant DNA. DNA was diluted 
in Opti-MEM Reduced Serum Medium without serum and mixed gently.
b. Tube 2 contained: 12.5 pi Lipofectamine 2000 and 1250 pi Opti-MEM. 
Lipofectamine 2000 was gently mixed before use and then diluted to the 
appropriate amount in Opti-MEM Medium. The complex was incubated for 5 
minutes at room temperature. Note: Proceeded to step c within 25 minutes.
c. After the 5 minute incubation, the diluted DNA was combined with diluted
Lipofectamine 2000 (tube 1 and 2). This was mixed gently and incubated for 20
\
minutes at room temperature. Note: Complexes are stable for 6 hours at room 
temperature.
The resulting DNA: lipofectamine complexes were added to each cultured dish with 
medium and mixed gently (total volume = 5 ml per 100 ml plate or 1 ml per 35 mm plate). 
Cells were incubated cells at 37°C in a CO2 incubator for 18-24 hours prior to testing for 
transgene expression. Media changed after 4-6 hours.
2.3 Lipofectamine 2000 transfection for HEK 293 cells
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2.4 Chemicals, drugs, and peptides
The sources o f the following chemicals and drugs are as listed: CaCl2, MgCl2, 
BaCl2, Gluconic acid, CsOH, ADPR, Mg(ATP)2, BAPTA, EGTA, W7 and Calmodulin 
(Sigma), Calmodulin Inhibitor Peptide (Calbiochem), and HEPES (BioShop).
2.5 Data analysis/stats
All population data are expressed as mean +/- standard error. Paired t-test was used to 
compare within groups, Students t-test was used to compare between two groups, and the 
ANOVA test was used to analyze multiple groups. The time constant of recovery (x) was 





3.1 Time-dependent inactivation of TRPM2 channels in HEK 293 cells
Administration of extracellular Ca2+, in the presence of intracellularly applied 
ADPR, results in TRPM2 channel activation; the resulting currents are abolished upon 
removal of extracellular Ca2+. Thus, with ADPR added to the ICS, channel activation can
r\  «
be controlled by varying extracellular Ca , as shown in Figure 6. The ability of 
extracellular Ca2+ removal to abolish TRPM2 current has been previously described 
(Csanady and Torocsik, 2009; Hara et al., 2002; McHugh et al., 2003; Starkus et al., 2007). 
During recordings with HEK 293 cells stably expressing TRPM2, I observed a time- 
dependent progressive decrease in TRPM2 current amplitude during prolonged 
extracellular Ca2+ (2 mM [Ca2+]) applications (Figure 6). In these experiments, the protocol 
for recording was as follows; whole-access was achieved in the presence of extracellular 
Ca2+ with ADPR added to the ICS. Under these conditions, the initial rate of current onset 
is limited by the diffusion rate of ADPR from the patch pipette to the cell interior. Currents
Q  t
were allowed to reach approximately 1 nA following which extracellular Ca was
I
removed and cells were continuously maintained in Ca -free solutions for 3 minutes. This
\
allowed sufficient time for ADPR to equilibrate with the cell interior and ensured that 
maximum currents amplitude would rapidly be reached upon re-application of extracellular 
Ca2+. The currents in whole cell recordings from HEK 293 cells stably expressing TRPM2 
were observed to reach a peak within a few minutes, then decay to a steady state in the 
continued presence of extracellular Ca2+ (Figure 6). This gradual decline in current 
amplitude in the continued presence of Ca2+ is referred to as inactivation. We reasoned that 
if inactivation is a Ca2+ dependent process, channels should progressively recover from 
inactivation following a time period in Ca2+-free ECS. With 0.3 or 1 mM ADPR added to
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the .ICS, I systematically varied the duration of Ca2+-free ECS between successive Ca2+ 
ECS applications allowing us to determine the time course of recovery following 
inactivation. Four time sessions were performed, 10 seconds, 30 seconds, 1 minute and 3 
minutes of Ca2+ free solution (Figures 7 and 8). The ratio of the peak currents generated by 
consecutive Ca2+ applications (P2/P1 Ratio) was used as an inactivation index. The time 
constant of recovery (x) for each recording condition (0.3 and 1 mM ADPR; n=4-9 and 
n=4-7) was determined from exponential fits applied to plots of P2/P1 versus time (sec) 
(Figure 9).
The following recordings were performed by varying the time interval of Ca2+-free 
solution administration to determine the extent of inactivation in the presence o f Ca .1  
observed a significant reduction in peak following inactivation in recordings with 10 sec of 
Ca2+-free solution administration (Figure 7A )., However, administration of Ca2+-free 
solution for 3 minutes resulted in a subsequent recovery of the second peak (Figure 7B). 
With evidence that TRPM2 has a time course of recovery following inactivation, we then 
determined whether time course of recovery from inactivation was dependent upon the 
concentration of ADPR. Two concentrations of 0.3 mM and 1 mM were utilized (Figures 8 
and 9). A peak-to-peak analysis was performed to determine the extent of recovery 
following inactivation. The analysis of the time constant of recovery indicated that the time 
required for TRPM2 to fully recover from inactivation was dependent on the concentration 
of ADPR. In the presence of 0.3 mM ADPR, the time constant for recovery was 23 




OCa2*  0 Ca 2+
Figure 6: Time-dependent inactivation in HEK cells stably expressing TRPM2. Large 
inward current recorded from a single HEK 293 cell stably expressing TRPM2 with the 
addition of 0.3 mM ADPR to the intracellular slution (ICS) showing the progressive 
inactivation in the presence of 2 mM extracellular Ca2+ (3 minutes of Ca2+ ECS 
application).
B 0 C a2+
Figure 7: Time course of recovery with varying times of Ca2+ 
administration. (A) 10 seconds of Ca2+-free solution administration. (B) 
Ca2+-free solution administration. Illustrating the recovery of 2nd peaks in 
the 1st peaks.
free solution
3 minutes of 
comparison to
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Figure 8: Recovery from inactivation with varying ADPR concentration. (A)-(B) 
Representative recordings from 4 different HEK 293 cells stably transfected with TRPM2. 
Recovery from inactivation was assessed by varying the duration of Ca2+-ffee solution 
applied between successive Ca applications. The ratio of the peak currents generated by 
consecutive Ca2+ applications (P2/P1 Ratio) was used as an inactivation index. As can be 
seen by comparing traces in (A) and (B); high ADPR (1 mM) slowed the recovery from
i
inactivation at both Ca -free time intervals shown (10 and 30 sec).
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Figure 9: Time course of recovery from inactivation is dependent on the concentration 
of ADPR. The time constant of recovery (x) under each recording condition (0.3 and 1 mM 
ADPR; n=4-9 and n=4-7) was determined from exponential fits applied to plots of P2/P1 
versus time (sec) of Ca2+-free solution administration.
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3.2 Inactivation as a Ca2+-dependent process
In previous recordings, cells were voltage-clamped at -60 mV. To determine the 
dependence o f inactivation on membrane potential, experiments were performed in which 
the holding potential was varied from -20 to -100 mV. Figure 10A illustrates that as the 
membrane is depolarized, the Iss/Ip (steady state to peak ratio) increases reflecting a 
decrease in inactivation. This is clearly evident when comparing currents recorded at -100 
mV with those recorded at -20 mV. As the membrane becomes more depolarized there is 
less driving force for the influx of extracellular Ca resulting in reduced inactivation 
(measured by Iss/Ip) (Figure 10). This supports the role of Ca influx to the inactivation- 
dependent process of TRPM2.
3.3 Extracellular Ca2+-dependent
I observed a change in inactivation by varying the membrane potential, suggesting 
Ca2+-dependence. To test this more directly, the following experiment was performed by
varying the extracellular Ca2+ concentration from 0.2 mM to 5 mM to determine the
\
consequence on the steady state to peak ratio o f TRPM2 currents. As shown with the 
representative traces in Figures 11A and 11B, application of a relatively low concentration 
Ca (0.5 mM) caused robust channel activation with little inactivation evident. As the 
extracellular [Ca2+] increased, inactivation was increased. Figure 11C demonstrates the 
relationship between Iss/Ip and extracellular [Ca2+].
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A  Holding Voltage
(mV): -lOOmV Ca2* -60mV Ca2* -20m V Ca2*
the holding voltage during whole cell recording. (A) Recording from a single cell. HEK 
293 cells were voltage-clamped at -100 mV at breakthrough. Ca2+ solution was 
administered for 3 minutes, followed by Ca -free solution for 3 minutes. The holding
voltage (Vh) was changed towards a more depolarized membrane potential and subsequent
^  I A  I
Ca solution and Ca -free solution were administered. The extent of inactivation was
determined by the Iss/Ip (steady state to peak ratio). (B) Analysis of the Iss/Ip with respect 
to Vh (-100 mV, standard error (SE) +/- 0.02, n=6; -80 mV, +/- 0.01, n=12; -60 mV, +/- 
0.03, n= 6 ;-40 m V ,+/-0.01, n= 5;-20 m V ,+/-0.01, n=l 1).
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A 0 Ca2+ 0 Ca2+ 0 Ca2+ B 0 Ca2+ 0 Ca2+
Extracellular[Ca2+]: 05mM 2mM 5mM Extracellular[Ca2+]: °-5mM 1mM 2mM
Figure 11: Extracellular [Ca ]-dependent inactivation. (A) and (B) single cell 
recordings from HEK cells using 0.3 mM ADPR in the ICS. Extracellular [Ca2+] of 0.5 
mM-5 mM was administered throughout recordings to determine the extent of inactivation. 




3.4 Dependence of inactivation on intracellular [Ca2+]
To determine the dependence of inactivation on intracellular [Ca2+] BAPTA (2- 
bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, fast Ca chelator/buffer) was 
administered within the ICS at 10 mM.
It is known that increasing intracellular [Ca2+] buffering, by utilizing chelators, 
reduces TRPM2 channel activation. However, the effect of high intracellular [Ca2+] 
buffering on inactivation has not been previously examined. I anticipated that buffering 
intracellular [Ca' \ would result in a reduction in TRPM2 inactivation, since Ca is 
required in synergy with ADPR for inactivation. The buffers utilized were BAPTA and 
EGTA. A computer software (Maxchelator) was utilized to determine the approximate 
intracellular free Ca concentration achieved in our ICS and to ensure this value was 
approximately equivalent between the 2 conditions. To determine the approximate free 
Ca2+ concentrations in the intracellular solution the concentrations of chelators (BAPTA or 
EGTA), total Ca2+ and Mg2+ concentrations, and the pH of the solution was utilized in the 
calculations. The administration of 10 mM BAPTA and 20 mM EGTA to the ICS reduced 
the intracellular free Ca concentration to approximately 25 and 15 nM respectively 
(Maxchelator). Buffering intracellular Ca2+ (with 10 mM BAPTA in the ICS) resulted in a 
significant reduction in the peak currents. More importantly, it also reduced the 
inactivation of TRPM2 in contrast to control recordings with 20 mM EGTA (Figures 12A- 
C). In summary, these results show that inactivation is dependent upon intracellular and 
extracellular [Ca2+] and the concentration of intracellular ADPR.
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Figure 12: Inactivation of TRPM2 is dependent on intracellular [Ca2+]. (A) Recording 
in presence of 10 mM BAPTA within the ICS, in contrast to (B) which contained control 
ICS (20 mM EGTA). (C) Analysis of Iss/Ip for control (n-25) and BAPTA containing ICS 
(n=7). (D) Peak amplitude for control (n=25) and BAPTA containing ICS (n=7). 
***P<0.0001.
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3.5 Administration of calmodulin
The previous results indicated the importance of [Ca j j  to Ca -dependent 
inactivation of TRPM2. We investigated the mechanism by which [Ca2+]i-mediated 
inactivation by testing the possible involvement of calmodulin. CaM is ubiquitously found 
and contains four EF hand motifs. Ca2+ binds to these motifs causing a structural 
rearrangement of CaM. This results in an increased affinity of CaM binding to various 
proteins (Gordon-Shaag et al., 2008).
It is well known that Ca2+-CaM promote Ca2+-dependent inactivation of Ca2+ 
permeable channels (e.g. VGCC and NMDARs). Recordings with 100 pM CaM in the ICS 
showed an increase in inactivation observed as a decrease in Iss/Ip (Figure 14C). This was 
a significant decrease in Iss/Ip (*P<0.05) in comparison to control recordings without CaM. 
In addition to a decrease in Iss/Ip, the presence of CaM results in a slower recovery of the 
second peak following inactivation. This is evident in comparing recordings with control 
and CaM containing ICS. In control recordings the second peak fully recovered following
A  i
the administration of 3-5 minutes of Ca -free solution (Figure 13A). In contrast, the 
second peak does not fully recover following the administration of 5 minutes of Ca -free 
solution in the presence of CaM (Figure 13B). To determine the time period of Ca2+-free 
solution which results in a full recovery of the second peak in the presence of CaM, I 
administered 10 minutes of Ca2+-free solution. The administration o f 10 minutes of Ca2+- 
ffee solution resulted in a full recovery of the second peak (Figure 14A). The slower 
recovery following inactivation provided the rationale for performing the time course of 
recovery following inactivation in the presence of CaM.
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Similar to the time course experiment with administered ADPR, I performed a time 
course study with 5 time points: 10 seconds, 30 second, 1 minute, 3 minutes, 5 minutes and 
10 minutes of Ca2+-ffee solution. A time course analysis is illustrated in Figure 16. It is 
evident that recordings with CaM containing ICS resulted in a slower recovery following 
inactivation that took approximately 10 minutes to fully recover.
3.6 Calmodulin inhibitors
CaM inhibitors were utilized to determine the role of CaM with respect to Ca - 
dependent inactivation. Membrane-permeable CaM inhibitor W-7 was administered to ICS 
and ECS at 10pM (Figure 15A). There was no significant difference in the Iss/Ip between 
W-7 and control recordings. Analysis Iss/Ip for CaM-inhibitory peptide administered to 
ICS at lOpM (Figure 15B), yielded a similar result. Although these results illustrated no 
significant difference in the Iss/Ip in comparison to the control group, this data is more 
difficult to interpret. Difficulties arise due to CaM inhibitors (inhibitory peptide and W-7) 
affecting activation. This is evident in Figures 15C and D, whereby the second peak is 
reduced. This reduction in the amplitude of the peak may be due to the inhibitors slowing 
the recovery of the channel following inactivation or an effect on activation. The reduction 
in amplitude due to the interaction with CaM inhibitors results in an inaccurate 
interpretation of Iss/Ip, since the peak in addition to the steady state is affected.
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Figure 13: Representative recordings used to determine the extent of peak recovery 
following inactivation. Comparison of the recovery of the 2nd peaks with respect to the 
initial peaks following the administration of Ca2+-free solution for a duration of 5 minutes. 
(A) Control recording showing a full recovery of the 2nd peak, (B) recording with lOOpM 
calmodulin in ICS demonstrating ; a slower recovery of the 2nd peak following the
I
administration of Ca -free solution.
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Figure 14: Inactivation of TRPM2 is dependent on calmodulin. Comparison of the 
duration of Ca2+-ffee solution administration required for a full recovery of the 2nd peaks 
with respect to the initial peaks. Representative recordings also illustrates the extent of 
inactivation of the 2nd peak measured by the Iss/Ip. (A) Recording illustrating a full 
recovery o f the 2nd peak following the administartion of Ca2+-free solution for a duration of 
10 minutes in the presence of lOOpM calmodulin in ICS (n=5), (B) control recording 







Figure 15: Determining the effect of calmodulin inhibitors on inactivation. (A)
Analysis o f Iss/lp for the membrane-permeable CaM inhibitor W-7 administered to ICS 
and ECS at lOpM, W-7(n=6) and control (n=8). (B) Analysis of Iss/lp for CaM-inhibitory 
peptide administered to ICS at lOpM, CaM-inhibitory peptide (n=10) and control (n=12). 
(C) Example recording with lOpM W-7 within the ICS and ECS, and (D) 10 mM CaM- 
inhibitory peptide to the ICS.
Figure 16: Time course of recovery from inactivation in the presence of calmodulin.
Analysis of the time constant of recovery (x) in recordings with control ICF (n=4-9) and 
100pM calmodulin in ICS (n=4-10) determined by exponential fits applied to plots of 
P2/P1 versus time (sec) of Ca -free solution administration.
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3.7 Effect of CaM mutants on inactivation
To further determine the role CaM plays with inactivation in TRPM2 CaM mutants 
were developed. Three functional dominant negative CaMl mutants (Peterson et al., 1999) 
were prepared by single point mutations at the EF hands. These mutations took place on 
either the N-terminus or C-terminus of CaMl. The four EF hands correspond to amino 
acids 21, 57, 94 and 130 on CaMl. CaMi^ mutant was prepared by substituting aspartate 
(D) for alanine (A) at EF hands 1 and 2 (Figure 5A). CaM3,4 mutant was prepared by 
substituting aspartate (D) for alanine (A) at EF hands 3 and 4 (Figure 5A). Lastly, 
substitutions at all four EF hands resulted with C a M ^ ^  mutant. Lipofectamine 2000 
transfection was used to determine whether CaM mutants had an effect on the extent of 
inativation observed in TRPM2 currents. A 3:1 desired DNA to GFP was utilized with 
Lipofectamine 2000 transfection.
Control recordings utilized HEK 293 cells stably expressing TRPM2. There was no 
significant difference in Iss/Ip between recordings under three conditions: control, no 
expression of GFP, and expression of both GFP and CaM mutants DNA (Figures 17A, B 
and C). The use of CaM 1,2,3,4 and CaM 3,4 was predicted to cause a complete reduction 
in Ca2+-dependent inactivation as seen previously in experiements utilizing L-type Ca2+ 
channels (Peterson et al., 1999).
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Figure 17: Calmodulin mutants have no effect on TRPM2 inactivation. Determining 
the extent of inactivation by utilizing functional dominant negative CaM mutants 
transfected into HEK 293 cells staby expressing TRPM2. (A) Analysis of Iss/Ip for Cam 
3,4 mutant (n=5), in contrast to control recordings (n=5) and recordings from cells not 
expressing GFP (n=5). (B) Analysis of Iss/Ip for Cam 1,2 mutant (n=7), control recordings 
(n=3) and cells not expressing GFP (n=3). (C) Analysis of Iss/Ip for Cam 1,2,3,4 mutant 




4.1 Summary of key findings
This thesis has characterized the properties of an inactivation mechanism 
encountered in HEK 293 cells stably expressing TRPM2. Various novel findings have 
resulted through this work as summarized below.
Inactivation of TRPM2 is dependent on:
1) the concentration of ADPR (Figure 9)
Q  É
2) Ca influx (Figure 10 illustrates that inactivation was reduced at more 
depolarized membrane potentials, consistent with a reduced driving force and 
less influx of Ca2+)
3) extracellular [Ca j  ; being almost entirely prevented when extracellular Ca 
was reduced to 0.2 mM (Figure 11 A)
4) intracellular free [Ca2+] (Figure 12)
The application of calmodulin resulted in a significant increase in inactivation. The time 
constant of recovery following inactivation was 241 sec which was significantly slower 
than 28 sec observed in control recordings (Figure 16), suggesting the involvement of CaM 
with the Ca2+-dependent inactivation of TRPM2.
4.2 Progressive time-dependent inactivation of TRPM2
Previous recordings from our lab and others, using HEK 293 cells stably expressing 
TRPM2, indicated the possibility these channels might be regulated by an inactivation 
process. TRPM2-mediated currents developed rapidly following the intracellular 
application of ADPR. The currents peaked within a few minutes and then decayed to a
n  I
steady state in the continued presence of extracellular Ca . Perraud, A.L. et al., (2001)
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described TRPM2 regulation with respect to ADPR and Ca2+ (Perraud et a l, 2001). They 
performed whole-cell recordings with varying ADPR concentrations in the ICS. In addition 
they included 10 mM BAPTA to buffer [Ca2+]i. Recordings with 0.3 and 1 mM ADPR 
resulted in a possible time-dependent inactivation (Perraud et al., 2001). Furthermore, they 
buffered free [Ca2+]i to 100 nM abolishing inactivation. Taken together, this hinted at a 
possible inactivation process which may be linked to [Ca24]. Whole-cell patch clamp 
recordings were performed with inducible TRPM2-expressing HEK 293 cells. The 
dependence on extracellular Ca for TRPM2 regulation was an important characteristic 
implemented in our recordings. The administration of Ca2+ containing ECS to ADPR 
within the ICS resulted in a robust current. The initial current was permitted to develop to 
approximately 1 nA and was then followed by the administration of Ca -free ECS, 
completely inhibiting the current. This protocol was utilized to ensure that a maximal peak 
current developed before accessing the extent o f inactivation. Application of Ca2+-free ECS 
for 3 minutes following breakthrough ensured complete diffusion of ADPR into each cell. 
The re-application of Ca containing ECS re-activated the inward currents carried by
V
cations in response to extracellular Ca application.
4.3 ADPR dose-dependent inactivation of TRPM2
The concentration-dependent activation of TRPM2 by ADPR has been described in 
the literature (Jiang et al., 2010; Perraud et al., 2001; Starkus et al., 2007). However, it is 
not known whether or not the concentration o f ADPR plays a role in TRPM2 inactivation. 
This thesis demonstrates the dependence of inactivation on [ADPR], Firstly, we performed 
experiments on HEK-293 cells stably expressing TRPM2 to ensure that ADPR provided
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the primary gating mechanism (Jiang et al., 2010; Perraud et al., 2001). In the absence of 
ADPR in the patch pipette, there was no current in HEK-293 cells stably expressing 
TRPM2. This indicated that HEK-293 cells stably expressing TRPM2 required 
exogenously administered ADPR. The initial concentration of ADPR utilized by Dr. 
Sharenberg’s group was 100 pM. The EC50 o f ADPR was approximately 130 pM, which is 
comparable to the EC50 o f 10-90 pM for gating of TRPM2 in HEK-293 cells (Perraud et 
a l.,2001).
Experiments in HEK-293 cells stably expressing TRPM2 were replicated with three 
varying ADPR concentrations. The administration of 100 pM ADPR in the ICS resulted in 
very slow activation (not shown), similar to previous reports (Perraud et al., 2001). 
However, under these conditions I observed a peak that developed which was not seen in 
data from Perraud et al., (2001). In addition, a steady state developed in the presence of 
extracellular Ca2+ following a peak amplitude in my recordings with 100 pM ADPR. This 
apparent inactivation (utilizing 100 pM ADPR in the ICS) was not observed by Perraud et
al., (2001). The inactivation I observed with lower [ADPR] was dependent on ensuring a
\ '
peak current developed before accessing inactivation. Others observed similar activation, 
and an apparent inactivation with 300 pM and 1 mM ADPR in the ICS (Figures 8A and B)
p
(Perraud et al., 2001). Different concentrations of ADPR (0.3-1 mM) evoked currents 
which peaked followed by decay to a steady state with similar Iss/Ip ratios at both 
concentrations (Perraud et al., 2001). Our application protocols allowed us to consistently 
measure peak currents, which may approximate the maximum current. In contrast this was 
not done by other groups and they did not attempt to measure inactivation (McHugh et al., 
2003; Perraud et al., 2001; Starkus et al., 2007).
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The discrepancies in inactivation between my results and Dr. Sharenberg’s may be 
due to the protocol utilized. Dr. Sharenberg’s group performed voltage ramps (increasing 
holding voltage linearly throughout a recording) of 50 ms spanning -100 to + 100 mV, 
which were delivered from a holding potential of 0 mV at 0.5 Hz over 200-400 seconds. In 
contrast, we did not utilize voltage ramps: our recordings were performed with cells held at 
-60 mV during whole-cell voltage-clamp recordings. Another difference was the chelators
a  I
used to buffer the free intracellular Ca . We utilized 20 mM EGTA, in contrast to the 10 
mM BAPTA that was administered to the ICS by Dr. Sharenberg’s group. EGTA is a Ca2+ 
chelator that exhibits high selectivity for Ca (Ellis-Davies and Kaplan, 1994). Similar to 
EGTA, BAPTA is highly selective for Ca2+ (highly selective to Ca2+ over Mg2+) and is 
used to control the levels of intracellular and extracellular Ca2+ (Tsien, 1980). However, 
differences between BAPTA and EGTA arise due to the extent of selectivity and ability to 
buffer Ca2+. Firstly, BAPTA is more selective for Ca2+ than EGTA (Ahluwalia etal., 2001; 
Luzio et al., 2007; Tsien, 1980). In addition, at physiological pH BAPTA binds arid 
releases Ca2+ approximately 50-400 times faster than EGTA. This is indicative of a faster 
rate o f association and dissociation for Ca ions (Ahluwalia et al., 2001; Luzio et al.,
2007). This results in a faster rate of buffering for BAPTA in comparison to EGTA.
>  2+
Therefore our experiments utilized a slower buffer of Ca , thus transient changes in
intracellular Ca may still develop in the vicinity of the channel. These transient influxes
of Ca result in a robust inactivation observed in my results evident in Figures 8A and B.
This is in contrast to the use of BAPTA which would sequester the levels of intracellular
Ca at a rapid rate, thus preventing Ca ions from having effects on the channel.
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In addition to ADPR being administered to the ICS, extracellular Ca2+ was also 
applied to activate TRPM2. Interestingly the removal of Ca2+ caused a fast closure of the 
TRPM2 channels abolishing the developing currents. This inactivity of the channel does 
not reverse until the re-application of extracellular Ca2+ solution. These observations are 
illustrated in Figures 6 and 7 and are consistent with previous literature (McHugh et al., 
2003; Starkus et al., 2007). In the next series of experiments we varied the duration of 
Ca2+-ffee ECS between successive Ca2+ ECS applications. The reasoning of these 
experiments was to determine if  inactivation of TRPM2 is a reversible process. We 
predicted that channels should progressively recover from inactivation following various
n  i
time durations of Ca -free ECS administration. The following sets of recordings were 
performed with 0.3 mM ADPR added to the ICS and the time periods were systematically 
varied. Figures 7A and B are representative recordings with 10 seconds and 3 minutes of 
Ca -free ECS administration. It is apparent in Figure 7A that the analysis of the 2 peak 
following re-administration of Ca2+ ECS to the 1st peak results in a significant reduction in 
peak currents following the 10 seconds time period of Ca2+-free ECS. By contrast, Figure 
7B is a representative recording whereby we varied the time period of Ca2+-ffee ECS to 3 
minutes and this resulted in comparable peak currents between the 2nd peak and 1st peak 
(close to 90% recovery measure by P2/P1). In summary, these results indicate that with 0.3 
mM ADPR in the ICS, the channel requires close to 3 minutes of Ca2+-ffee ECS to fully
A t
recover the initial peak current once Ca ECS is re-administered.
To determine a time constant of recovery following inactivation, we systematically 
performed recordings with varying the time period of Ca2+-ffee ECS utilizing four time 
intervals: 10 seconds, 30 seconds, 1 minute and 3 minutes. Ideally each time interval would
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have been tested in the same cell to minimize variability amongst cells. However, the 
prolonged recording durations needed could not be achieved experimentally due to the 
progressive deterioration of recording quality following repeated and prolong TRPM2 
activations. Therefore, we tested various intervals on different cells. Nevertheless, in 3 
stable and long lasting recordings we tested all four time intervals of Ca2+-ffee ECS 
administration. The time course of recovery from the pooled recordings at various time 
intervals was comparable to these 3 recordings with multiple time intervals of Ca -free 
ECS administration. This helped validate our experimental approach. We then varied the 
ADPR concentration used in recordings to ImM in order to determine if  the recovéry from 
inactivation was dependent on ADPR concentration. The ratios of P2/P1 were employed as 
an inactivation index. Representative recordings using Ca2+-ffee ECS intervals of 10 
seconds and 30 seconds are illustrated in Figure 8. Recordings with 1 mM ADPR in the 
ICS demonstrated a slower recovery of inactivation in comparison to 0.3 mM ADPR 
(Figure 8A and B). The time constant of recovery (x) under each recording condition (0.3 
and 1 mM ADPR; n=4-9 and n=4-7) was determined from exponential fits applied to plots 
of P2/P1 versus time (sec) (Figure 9). This analysis demonstrated that recovery following 
inactivation of TRPM2 is dependent on ADPR concentration. Indeed, the time constant in 
the presence of 0.3 mM ADPR was 23.2 seconds, whereas recovery was slowed to 42.8 
seconds in recordings using 1 mM ADPR (Figure 9).
4.4 Extracellular [Ca2+]-dependent inactivation
It has been demonstrated that extracellular Ca plays an important role in TRPM2 
channel function. The removal of extracellular Ca2+ abolishes the activity of TRPM2
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channels (Hara et al., 2002). The influx of extracellular Ca2+ in the presence of ADPR is 
sufficient to maintain activation of the channel (Csanady and Torocsik, 2009; McHugh et 
al., 2003; Starkus et al., 2007).
With this in mind, I focused my next set of experiments on the role of extracellular 
Ca2+ on inactivation. The apparent inactivation observed in Figures 6 and 7, occurred in 
recordings performed with 2 mM extracellular Ca2+. Under these conditions there was a 
significant inactivation process observed. To determine the dependence of inactivation on 
extracellular Ca2+, we varied the extracellular [Ca2+]. It was evident that as the extracellular 
[Ca2+] increased there was an increase in inactivation as measured by a decrease in Iss/Ip 
(Figure 11). It is apparent in Figure 11A and B that inactivation is more sensitive to 
varying the extracellular [Ca ] than activation. The amplitudes of the currents were 
comparable in Figure 11B at all three extracellular [Ca2+]: 0.5 mM, 1 mM and 2 mM. 
However, inactivation (measured by Iss/Ip) was significantly different. In Figure 1 IB, the 
Iss/Ip for the application of 0.5 mM extracellular [Ca2+] was approximately 1:1 indicating 
the absence of inactivation. In comparison, inactivation was observed with the 
administration of 2 mM extracellular [Ca2+]. Although inactivation was different amongst 
the different extracellular [Ca2+], the peak currents (activation) were similar. While 
inactivation has not been studied extensively, Dr. Penner’s group briefly experimented with 
varying extracellular [Ca2+] and noted that inactivation was not affected (Starkus et al., 
2007). Increasing extracellular [Ca2+] from a nominally divalent free solution (no 
exogenous buffers), to 0.2 mM and 1 mM did not alter the extent of current inactivation 
(Starkus et al., 2007). However, the peak currents were significantly different increasing 
from -0.2 nA to -8 nA from nominally divalent free solution to 1 mM. In contrast to Dr.
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Penner’s group, we observed that inactivation is dependent on extracellular [Ca2+], In 
addition, the peak currents did not vary significantly in our recordings! It is important to 
note that Dr. Penner’s group administered 1 mM ADPR in the ICS and buffered the ICS 
with 10 mM BAPTA. These inconsistencies in peak current can also be attributed to the 
voltage ramp protocol utilized during whole-cell recordings by Dr. Penner’s group. 
Recordings from Dr. Penner’s group took place immediately after break through, with a 
single application of Ca2+ solution (Starkus et al., 2007). This protocol would make 
inactivation more difficult to interpret since the currents may be affected by both activation 
and inactivation. In addition, ADPR may have not fully diffused throughout the cell at the 
time o f recording. In comparison, my protocol was developed to ensure that TRPM2 
currents had fully developed and that ADPR had adequate time to diffuse throughout the 
cell before studying the extent of inactivation.
An additional set of experiments were performed by varying the holding voltage 
during recordings. The holding voltage was varied from -20 to -100 mV, in -20 mV 
intervals. Figure 10A shows that as the membrane is hyperpolarized there is a decrease in 
Iss/Ip indicating an increase in inactivation. This is consistent with an increased driving 
force o f Ca2+ ions as the membrane is hyperpolarized, which supports the dependence of 
inactivation on extracellular [Ca ]. A linear fit was performed utilizing data from varying 
holding voltages. Figure 10B illustrates this analysis of Iss/Ip to the holding voltage and 
predicts that there would be an abolishment in inactivation at approximately +50 mV. This 
value approximates the reversal potential (Erev) of Ca2+. The membrane potential at which 
an ion has no net charge across the membrane is termed as the Erev. At the Erev there is a 
switch in the overall direction of the ion flow. This predicted value is consistent with
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literature that performed voltage clamp recordings in myocytes from isolated bull-frog 
atrium (Campbell et al., 1988). Under the following extracellular solution conditions: 2-5 
mM Ca2+ and 0-5 mM Mg2+, the predicted Erev was computed to be +51.5 +1-2.4 (n=7) 
(Campbell et al., 1988). As the holding voltage approaches the Erev of Ca of 
approximately +50 mV (Campbell et al., 1988), the outward and inward rate of ion flow are 
the same and inactivation of TRPM2 channel is abolished. Therefore, experiments in which 
the holding voltage and extracellular [Ca24] were varied provide evidence for the 
dependence of inactivation on extracellular Ca .
4.5 Intracellular [Ca2+]-dependent inactivation
Intracellular Ca2+ is necessary for TRPM2 channel gating by ADPR. In addition, 
the mechanism of [Ca24]i-mediated TRPM2 activation has been linked to a CaM-binding 
domain (Csanady and Torocsik, 2009; Du et al., 2009; Tong et al., 2006). The following 
sets of experiments were performed to determine the role of intracellular Ca2+ in the 
inactivation of TRPM2 channels. Recordings with 300 pM ADPR resulted in a rapid 
increase in current which peaked within 10-30 seconds. However, the peak current 
developed much slower in recordings from Dr. Sharenberg’s and Dr. Penner’s groups 
(Perraud et al., 2001; Starkus et al., 2007). The slower development of the peaks may be 
due to the protocols used in recordings. Both groups utilized BAPTA to buffer the
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intracellular Ca levels. This is in contrast to the recordings we performed with EGTA. 
The approximate free [Ca2+]i levels of both experimental conditions are 20-30 nM, which is 
comparable to 15 nM free [Ca2+]¡in our experiments with EGTA buffering (Maxchelator). 
Although the levels of free [Ca2+]i are similar in comparison to literature, the use of
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BAPTA (fast-buffer) in the literature results in a fast rate of Ca2+ buffering, reducing the 
effect of Ca2+on the channel (Ahluwalia et al., 2001; Luzio et al., 2007).
Figures 12A and B are representative recordings with the administration of 10 mM 
BAPTA and 20 mM EGTA (control) in the ICS. The large reduction in peak current is 
clearly evident in Figure 12A. The peak current amplitude (pA) was compared for both
control and BAPTA-containing recordings. There was a significant difference in peak
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current between the two groups. This further supports the importance of intracellular Ca 
for TRPM2 channel activation. This finding is in accordance to previous literature where 
buffering o f intracellular free [Ca2+] to approximately 20-30 nM was reported to 
significantly reduce peak current amplitudes (0.4-0.6 nA) (McHugh et al., 2003; Perraud et 
al., 2001; Starkus et al., 2007).
In addition to the significant reduction in peak current with the administration of 10 
mM BAPTA, there was little inactivation observed (total abolishment o f inactivation in the 
example recording, Figure 12A). Figure 12C represents the analysis of Iss/Ip for both 
control and BAPTA-containing recordings. There was a significant reduction in
V
inactivation observed in the group of recordings with BAPTA-containing ICS. Dr. Penner’s 
and Dr. Scharenberg’s groups have published recordings with an apparent inactivation 
process. Recordings from Dr. Penner’s group utilized 10 mM BAPTA to buffer the 
intracellular free [Ca2+] to approximately 30 nM (Starkus et al., 2007). Under these
conditions, recordings show that there is an apparent inactivation. Contrary to this finding,
i
I have shown that under similar buffering conditions there is a significant reduction in 
inactivation (Figures 12A and C). Dr. Scharenberg’s group showed similar results with an 
abolishment o f inactivation under similar buffering conditions (Perraud et al., 2001). The
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contradictory results with respect to inactivation under the buffering conditions described 
may result from the differing protocol used. However, the difficulties with this conclusion 
arise since both groups utilized voltage ramp protocols. Our results provide strong evidence 
for the dependence inactivation on intracellular [Ca2+].
4.6 Calmodulin as the Ca2+ sensor in L-type Ca2+ channel inactivation
The first evidence of a possible mechanism of Ca2+-sensitive inactivation, which 
limits Ca2+ channel activity was discovered in Paramecium (Brehm and Eckert, 1978). 
Intracellular [Ca2+] was determined to be essential to the inactivation process of voltage­
gated calcium channels (Bechem and Pott, 1985a; Brehm and Eckert, 1978; Imredy and 
Yue, 1994). Experiments utilizing L-type Ca2+ channels provided an insight on the 
mechanism of Ca2+-dependent inactivation (Imredy and Yue, 1994; Zuhlke and Reuter, 
1998). The importance of intracellular [Ca2+] was established with results demonstrating 
that Ca2+ chelators reduced inactivation (Bechem and Pott, 1985a; Bechem and Pott, 
1985b; Imredy and Yue, 1994; Romanin et al., 1992). The C-terminal tail of the aie
v
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subunits was the region which was first identified to be responsible for Ca dependent 
inactivation in L-type calcium channels (de et al., 1995; Zhou et al., 1997). To determine 
the specific location o f Ca2+ binding site on the C-terminal tail, mutation of sequence 
downstream of the EF hands were performed. This sequence was similar to a CaM 
consensus IQ motif, IQXXXRGXXXR (Rhoads and Friedberg, 1997; Saimi and Kung, 
2002). Mutations of this IQ-motif in the C-terminal tail prevented CaM binding and also 
blocked Ca2+-dependent inactivation (Qin et al., 1999; Zuhlke et al., 1999; Zuhlke et al., 
2000; Zuhlke and Reuter, 1998). The development of CaM mutants determined the role of
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CaM with respect to Ca2+-dependent inactivation. Peterson et al. coexpressed L-type 
channels and mutant CaM. These CaM mutants contained selective mutations at either the 
N-terminal or C-terminal lobe, or at both of the lobes thus making mutants that had Ca 
binding impairment (Peterson et al., 1999). The overexpression of CaMi^ mutant, which 
lacked Ca binding in the N-terminal lobe of CaM, did not affect Ca -dependent 
inactivation. In contrast, CaM3,4 mutant, which lacked Ca binding in the C-terminal lobe 
provided a clear abolishment of Ca2+-dependent inactivation (Peterson et al., 1999). These
9+experiments with dominant negative mutants of CaM suggested that CaM is the Ca 
sensor for inactivation of L-type calcium channels. In addition, the dominant negative 
effect of the CaM mutant in the presence of endogenous CaM implies that CaM is 
constitutively tethered to the channel (Peterson et al., 1999). This is evident, since 
endogenous CaM would have mediated inactivation if mutant CaM was not tethered to the 
channel. In summary, an increase in intracellular [Ca j  results in Ca binding to the 
constitutively tethered CaM. This Ca2+-CaM complex then binds to the IQ-motif causing 
Ca -dependent inactivation (Peterson etal., 1999).
\
4.7 Calmodulin as the Ca2+ sensor in TRPM2 regulation
94-The importance of extracellular Ca to TRPM2 channel regulation suggested a 
possible extracellular site of action for Ca2+ (Starkus et al., 2007). However, further 
research indicated that the importance of extracellular Ca to TRPM2 channel regulation 
was due to the influx of Ca2+ (Du et al., 2009; McHugh et al., 2003; Starkus et al., 2007; 
Tong et al., 2006). The strong dependence on intracellular [Ca ] for TRPM2 regulation
94-provided two alternative mechanisms involving intracellular Ca (McHugh et al., 2003;
59
Starkus et al., 2007; Tong et al., 2006). The first mechanism involves a direct interaction of 
intracellular Ca with an EF-hand on the channel. The second mechanism involves the 
interaction of intracellular Ca2+with calmodulin (McHugh et al., 2003; Starkus et al., 2007; 
Tong et al., 2006; Zuhlke and Reuter, 1998). Tong et al. (2006) investigated the
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involvement of CaM as a Ca sensor for activation of TRPM2. Firstly they explored the 
role o f CaM by co-expression of either CaM or the CaM dominant negative mutant 
(CaMMux). The functional consequences of the resulting transfections were determined by 
Ca2+ imaging of single transfected cells (Tong et al., 2006). The co-expression of CaM in 
TRPM2 expressing HEK 293 cells did not significantly affect changes in intracellular 
[Ca2+], which suggested endogenous CaM is sufficient to produce maximal activation of 
TRPM2 channels (Tong et al., 2006). In contrast the co-expression of CaMMux blocked the 
increase in intracellular [Ca2+]. The resulting inhibition of the intracellular [Ca2+] suggests 
that CaMMur competes with endogenous CaM for the same TRPM2 binding site (Tong et 
al., 2006). A similar mechanism has been demonstrated in L-type Ca channels as 
mentioned earlier (Peterson et al., 1999). This mechanism involves CaM being 
constitutively tethered to a region in the N-terminus of the aic subunit (Peterson et al., 
1999). Ca2+ influx results in an increase in intracellular [Ca2+] and subsequently a stronger 
interaction o f  Ca2+ with the tethered CaM. This Ca2+-CaM complex interacts with the IQ- 
motif resulting in structural rearrangement which facilitates Ca2+-dependent inactivation 
(Peterson et al., 1999; Tong et al., 2006). Although both channels exhibit similar Ca2+-CaM 
regulation mechanisms, it is not known whether CaM is constitutively tethered to TRPM2. 
They also demonstrated that TRPM2 and either CaM or CaMMUT undergo direct interaction 
through co-immunoprecipitation experiments. Secondly Tong et al. (2006) determined that
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CaM associated with TRPM2 through Ca2+-dependent and also Ca2+-independent binding. 
This was demonstrated through immunoprécipitation experiments in the presence o f 100 
pM Ca and 5 mM EGTA. To identify regions of interaction, Tong et al. (2006) prepared 
constructs consisting of either the TRPM2 N terminus (TRPM2-N, amino acids 1-730) or C 
terminus (TRPM2-C, amino acids 1060-1503) (Tong et al., 2006). They concluded that 
there appears to be two CaM binding sites on TRPM2 (Tong et al., 2006). There appears to 
be a weak Ca2+-independent binding of CaM to TRPM2 that occurs at the C-terminus. In 
contrast, there is a strong Ca -dependent interaction of CaM with the N-terminus of 
TRPM2 (Tong et al., 2006). As aforementioned, there are numerous CaM binding domains 
that have been described in literature. One in particular is the IQ motif consensus region 
(IQXXXRGXXXR) (Rhoads and Friedberg, 1997; Saimi and Kung, 2002). There is a 
recognized IQ-like sequence found at amino acids 406-416 (IQDIVRRRQLL) of TRPM2 
(Tong et al., 2006). They confirmed that mutation of two amino acids in the IQ-like motif 
was sufficient to cause significant abolishment of the binding of CaM to this sequence 
(Tong et al., 2006). However, even in the presence of this mutation CaM binding to full-
V
length TRPM2 was still observed. In summary, they demonstrated that the IQ-like motif of 
TRPM2 is essential for die binding of CaM and suggested the possibility of more than one 
possible CaM binding region. This was the case with L-type Ca channels, whereby CaM 
was the essential Ca sensor for both Ca -dependent inactivation and activation (Zuhlke
• j i
et al., 1999). The role CaM played with opposing biological effects made L-type- Ca 
channels unique. The possibility of more than one CaM binding site on TRPM2 poses the
n  I
question of whether activation and inactivation are both linked to CaM as the Ca sensor.
61
4.8 Calmodulin confers an increase in inactivation
Starkus et al. (2010), determined that TRPM2 activation approached 6 nA (slow 
activation) at a concentration of 10 pM of ADPR which was close to the EC50 value in the 
absence o f exogenous buffers (Hara et al., 2002; Starkus et al., 2010; Zuhlke et al., 1999). 
In contrast, administration of 100 pM CaM to the ICS resulted in rapid activation with 
maximal currents exceeding 16 nA. The observed increase in the peak currents may be due 
to the increased sensitivity of Ca2+ due to the elevated CaM near the TRPM2 channel 
(Starkus et al., 2007). These studies demonstrated that CaM mediated Ca -dependent 
activation. Contrary to this, our results suggest that CaM did not have a significant effect 
on Ca -dependent activation. This was determined by the lack of significance between 
activation rates amongst recordings containing control ICS and CaM-containing ICS (data 
not shown). However we observed a possible Ca -dependent inactivation process involved 
with administered CaM which is a novel finding in TRPM2 channels. Figure 13A and B 
illustrate representative recordings with 100 pM CaM to the ICS and control ICS 
respectively. Recordings with administered CaM in the ICS indicated an increase in
V
inactivation observed as a decrease in Iss/Ip Figure 14C. This was a significant decrease in 
Iss/Ip (*P<0.05) in contrast to control recordings without CaM. The decrease is indicative 
of an increase in the extent of inactivation. In addition, I observed that the 2nd peak took 
much longer to recover following the application of Ca -free ECS in comparison to 
recordings with control conditions (Figure 14A and B). Control recordings were performed 
with the time period of Ca2+-free ECS of 3 minutes, which resulted in approximetely 90% 
recovery of the P2/P1 (inactivation index) (Figure 14 B and Figure 13 A). Furthermore, this 
inactivation index was significantly reduced in recordings with 100 pM CaM in the ICS
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(Figure 13B) indicating that TRPM2 channels took longer to recover following inactivation 
in the presence o f exogenous CaM. When the time period of Ca2+-ffee ECS was increased 
to 5 minutes, the inactivation index of the second response increased indicating the 2nd 
peak was more comparable to the 1st peak (Figure 14A). This observation provided the 
rationale for performing the time course of recovery following inactivation in the presence 
of 100 pM CaM. The ratio of P2/P1 was utilized as an inactivation index similar to 
previous analysis of the [ADPR]-dependence on inactivation. We systematically performed 
recordings varying the time period of Ca2+-ffee ECS at six time points: 10 seconds 30 
seconds, 1 minute, 3 minutes, 5 minutes and 10 minutes. The addition of the 5 and 10 
minutes time periods of Ca2+-free ECS was utilized to ensure full recovery following 
inactivation. The time constant of recovery (t) under each recording condition (0.3 mM 
ADPR and 0.3 mM ADPR in the presence of 100 pM CaM; n=4-9 and n=4-10) was 
determined from exponential fits applied to plots of P2/P1 versus time (sec) (Figure 16). 
The time constant in the presence of 100 pM CaM (t=241 seconds) suggests that the 
recovery following inactivation is significantly slower compared to recordings under
V
control conditions (t=28.3 seconds)(Figure 16). In addition to our results suggesting CaM 
increased the extent of inactivation as measured by a decrease in Iss/Ip (Figure 13 A), the 
significantly larger time constant in the presence of CaM suggests a possible role of CaM 
as the Ca2+ sensor in inactivation.
4.9 CaM inhibitors and mutagenesis
To further investigate the role of CaM as a possible Ca2+ sensor in Ca2+-dependent 
inactivation we explored the use o f CaM inhibitors. An effect on inhibition would provide
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further evidence for the invovlement of CaM (Armstrong, 1989; Chad and Eckert, 1986). 
Two CaM inhibitors (W-7 and CaM inhibitory peptide) were used to determine their 
effects on inactivation. Figure 15A represents an analysis of the Iss/Ip in the presence of 
membrane-permeable CaM W-7 to ICS and ECS at 10 pM. However, there was no 
significant difference in the Iss/Ip between W-7 and control recordings. Figure 15B 
illustrates the analysis Iss/Ip for CaM-inhibitory peptide administered to ICS at 10 pM, 
which yielded similar results with respect to inactivation measured by the Iss/Ip. On the 
other hand, the effect of both inhibitors on the 2nd peak are clearly observed in Figure 15C 
and D. Although W-7 appears to have a larger impact on the 2nd peak, both results suggest 
that the interpretation of this data is difficult to understand. The possibilty of CaM being 
the Ca2+ sensor for both activation and inactivation would suggest that a CaM inhibitor 
would affect both processes. The difficulties in interpretation of these experiments stem in 
whether the reduction in the amplitude of the 2nd peak is due to slower recovery following 
inactivation or an effect of the inhibitors on activation. Therefore, this reduction in peak 
currents makes the analysis of Iss/Ip difficult to entirely underdstand. In agreement to this 
interpretation, the administration of 10 pM calmidazolium did not effect the extent of 
inactivation or the peak currents (data not shown). In contrast, Starkus et al. demonstrated 
that 2 pM calmidazolium in the ECS strongly inhibited TRPM2 peak currents and 
activation (Starkus et al., 2007). However, other research has demonstrated that various 
CaM inhibitors had no effect on Ca2+-dependent activation or inactivation. For example, 
Xia et al. (1998) performed patch-clamp experiments on small-conductance calcium- 
activated potassium-channels (SK channels) a  subunits. They concluded that the 
application of 10 pM calmidazolium or 10 pM CaM-inhibitory peptide did not affect peak
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currents that developed with 1 pM Ca2+ (Xia et al., 1998). Varying concentrations of 
calmidazolium (1-10 pM) exhibited similar results in L-type Ca channels (hnredy and 
Yue, 1994; Victor et al., .1997; Zuhlke and Reuter, 1998). This lack of effect on regulation 
may be due to CaM being permanently tethered to the channel, and thus not accessible to 
these inhibitors (Peterson et al., 1999; Pitt et al., 2001; Zuhlke and Reuter, 1998). In 
addtion calmodozolium and other CaM inhibitors may have lower affinities for 
constititively tethered CaM (Peterson et al., 1999; Zuhlke and Reuter, 1998). The CaM 
inhibitor would be expected to inhibit inactivation if  CaM acted as a free molecule in the 
cytosol, however CaM may indeed be tethered. Constitutively tethered CaM to the channel 
is a possibilty for TRPM2, and this mechanism would be similar to the mechanism 
demonstrated in L-type calcium channels (Peterson et al., 1999; Pitt et al., 2001; Zuhlke 
and Reuter, 1998).
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An alternative set of experiments to determine the role o f CaM with respect to Ca 
dependent inactivation utilized CaM mutagenesis. CaM mutants were prepared by single 
point mutations o f the EF hands at either the N-terminal (CaMi>2) or C-terminal lobe
V
(CaM3,4) or both (CaMi)2)3)4). Figure 17 compares recordings from the three mutants CaMi)2 
(n=7), CaM3,4 (n=5) and CaMi>2(3,4 (n=6). There were no significant differences amongst 
the mutants and control groups with respect to Iss/Ip. The expected outcome would have
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predicted in an abolishment of Ca -dependent inactivation with CaM3,4 and CaMi)2,3,4 
(Peterson et al., 1999). The rationale behind the expected results is due to the selectivity of 
CaM binding sites. Two sites on CaM (N terminal and C terminal lobes) play different 
roles with respect to regulating the channel (Peterson et al., 1999). This selectivity of CaM 
is well described in L-type Ca2+ channels whereby the C-terminal lobe is responsible for
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Ca2+-dependent inactivation and the N-terminal lobe of CaM is responsible for Ca2+-
I
dependent activation. However, other VGCC’s such as P/Q-type Ca channels
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demonstrated the opposite selectivity (Wykes et al., 2007). Ca binding to the C-terminal 
lobe o f CaM induces Ca -dependent activation and N-terminal lobe of CaM induces Ca - 
dependent inactivation of P/Q-type Ca2+ channels (Wykes et al., 2007). In summary, the 
observed effect on Ca -dependent inactivation utilizing CaM inhibitors indicates that CaM 
is accessible to these inhibitors and may be free in the cytosol. Further support for the 
possibility o f CaM being free in the cytosol and not being constitutively tethered to the 
channel, arose due to the lack of results with CaM mutants.
4.10 Physiological and pathophysiological roles of TRPM2
Although TRPM2 is expressed predominately in the brain, it has been detected in 
many other tissues. Currents from native TRPM2 have been recorded in various cell lines 
including a neutrophil cell line (Heiner et al., 2003) and CRI-G1 insulinoma cells (Inamura 
et al., 2003). Togashi et al. (2006) demonstrated a synergistic effect of heat on intracellular 
cADPR in pancreatic P-cells which resulted in Ca influx. The subsequent Ca influx 
provides a possible role for cADPR in the activation of TRPM2 at normal body 
temperatures, and regulating insulin secretion in pancreas (Jiang et al., 2010; Togashi et al., 
2006).
Another possible physiological role of TRPM2 depends on the production of 
reactive oxygen species (ROS). ROS, for example H2O2, cause ADPR production further 
resulting in activation of TRPM2 channels (Hara et al., 2002; Kuhn et al., 2005; Perraud et 
al., 2005). The role of TRPM2 with endothelial permeability was demonstrated by
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administering H2O2. This resulted in an increase in [Ca24]¡ through the opening of TRPM2 
channels, increasing endothelial permeability (Hecquet et al., 2008; Hecquet and Malik, 
2009; Kuhn et al., 2005; Perraud et al., 2005).
In addition, TRPM2 channels play a role in the production of cytokines from 
immune cells during inflammation. Inflammation is a biological response which recruits 
proteins and inflammatory cells from the bloodstream to initiate healing and repair of the 
damaged area (Yamamoto et al., 2008). The inflammatory response is controlled by a 
numbers of processes, including cytokines. Chemotactic cytokines (chemokines) play a 
crucial role with respect to bringing inflammatory cells such as neutrophils and monocytes 
from the blood to damaged tissues (Jiang et al., 2010; Luster, 1998; Yamamoto et al., 
2008). During inflammation neutrophils produce various antimicrobial agents including 
ROS (Yamamoto et al., 2008). One subfamily of chemokines, CXCL8, has been 
demonstrated to be produced by ROS, including H2O2 (Jiang et al., 2010; Josse et al., 
2001). An increase in [Ca2+]i through extracellular Ca2+ influx results in a production of 
certain cytokines, including CXCL8 (Feske et al., 2001; Wilson et al., 1993; Yamamoto et 
al., 2008). However, the mechanism was unknown, until Yamamoto et al. (2008), 
demonstrated that H202-induced production of CXCL8 from human monocytic cells is 
dependent on TRPM2 (Jiang et al., 2010; Yamamoto et al., 2008).
TRPM2 has been associated with various diseases such as Alzheimer’s disease 
(AD), Parkinson’s disease (PD), Western Pacific amyotrophic lateral sclerosis (WP-ALS), 
ischemic stroke and bipolar disorder (Hermosura et al., 2008; Hermosura and Gamito, 
2007; Jiang et al., 2010; Xu et al., 2006; Xu et al., 2009). One of the common 
characteristics of these diseases is oxidative stress, which results in an unregulated rise in
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[Ca2+]i (Bamham et al., 2004). However the mechanisms or pathways in which TRPM2 
affects these pathologies are unknown. For example, bipolar disorder (BD) has been linked 
to changes in intracellular [Ca2+] which alters homeostasis (Xu et al., 2006). TRPM2 
expression has been found in B-lymphoblast cell lines (BLCLs). Interestingly, research has 
shown that TRPM2 expression was significantly lower in BLCLs from BD-I with high 
basal intracellular Ca2+ levels (Yoon et al., 2001). This in comparison to BD-II patients 
with normal basal intracellular levels of Ca2+ (Yoon et al., 2001). Altered expression of BD 
protein was demonstrated by Yoon et al. (2001), whereby sustained increases in 
intracellular [Ca2+] resulted in a reduction in TRPM2 niRNA levels in BLCLs, promoting 
short and long isoforms of TRPM2. They also provided evidence for a link between 
variation of TRPM2 and altered intracellular [Ca2+] homeostasis in BD by illustrating a 
relationship between TRPM2 gene variant (intron 19 single nucleotide polymorphisms, 
(SNPs)) and elevated in intracellular [Ca2+] in BD-I patients (Xu et al., 2006). Additionally, 
TRPM2 variants with mutations resulting from a single amino acid substitution 
(Asp543Glu) in SNPs in exon 11 were found in BD-I patients (Xu et al., 2006; Xu et al.,
V '
2009). These findings suggest that TRPM2 gene variants increase the risk of BD and 
demonstrated the importance of targeting TRPM2 due to its involvement in the 
pathophysiology of BD (Xu et al., 2006).
In addition to BD, ALS, and PD have also been implicated with altered intracellular 
[Ca2+]. TRPM2 studies were spurred on by a high occurrence of ALS and PD (two related 
neurodegenerative disorders) in three geographical areas. A TRPM2 variant (TRPM2pl018L) 
was found in a case study in both ALS and PD in the subset of Guam (ALS-G and PD-G). 
This variant was represented by a missense mutation with a substitution replacing Pro1018
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for Leu1018 (Hermosura et al., 2008). The substitution may prevent proper functional 
formation which is achieved with Pro1018. This would be indicative of the inability to 
maintain ion flow and provides evidence for the severely low levels of both Mg2+ and Ca2+. 
Further research by Hermosura et al. determined that this mutation resulted in a channel 
that could not sustain Ca2+ influx compared to wild-type TRPM2 channels in the presence 
of H2O2 induction. The reduced Ca flow was caused by the rapid inactivation of TRPM2 
channels exhibiting this mutant. Thus the inability of TRPM2 variant (TRPM2pl018L) to 
maintain ion influx through its rapid inactivation resulted in effects that give rise to 
neurodegenerative diseases.
4.11 Future directions
The work in this thesis has increased our understanding of the mechanism of Ca - 
dependent TRPM2 channel inactivation. The following future directions include: extending 
work on previous experiments, characterizing the binding of CaM to TRPM2 and 
performing subsequent site directed mutagenesis on TRPM2.
To characterize the association of CaM with the N and C-termini of TRPM2, a pull­
down assay should be performed. This would replicate experiments performed by Tong et 
al. (2006), which suggested separate sites of binding Ca2+-dependent and Ca2+-independent 
binding (Tong et al., 2006). In addition, site directed mutagenesis at either the N  or C- 
terminus should be performed. The TRPM2-N-Terrn-CaMmut and TRPM2-C-Term- 
CaMmut should be unable to bind CaM and testing these mutant channels for the presence 
or absence of inactivation would permit determination of the role of either region to 
inactivation. The rationale for using these mutants was due to the findings by Tong et al.
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(2006), which suggested the possibility of more than one CaM binding site on TRPM2 
(Tong et al., 2006). Since the N-terminus is involved with activation of TRPM2, we 
hypothesize that inactivation would be abolished by TRPM2-C-Term-CaMmut.
4.12 Significance of this work
We have focused the present experiments upon the characterization of the TRPM2 
channel, which is a novel disease candidate due to its involvement with cell death and it’s
o  I
implication with various diseases. We have demonstrated that Ca -dependent inactivation 
of TRPM2 is dependent on: ADPR concentration, extracellular Ca concentration and 
intracellular Ca2+ concentration. We have demonstrated the possibility of CaM acting as the
A  I
Ca sensor in both activation and inactivation of TRPM2. The lack of results yielded from 
the CaM mutants suggest that endogenous CaM was acting in the presence of the mutants, 
indicating that further studies on the involvement of CaM will be required to folly 
understand its role in TRPM2 inactivation.
Our results will advance our understanding of the role of TRPM2 inactivation in the 
maintainenance of physiological intracellular [Ca2+]. Therefore, understanding TRPM2 
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